These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9799169)

  • 1. Temporal trends in the progression of human immunodeficiency virus disease in a cohort of drug users.
    Webber MP; Schoenbaum EE; Gourevitch MN; Buono D; Chang CJ; Klein RS
    Epidemiology; 1998 Nov; 9(6):613-7. PubMed ID: 9799169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users.
    Barber Y; Rubio C; Fernández E; Rubio M; Fibla J
    J Infect Dis; 2001 Nov; 184(10):1279-88. PubMed ID: 11679916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gender, age, transmission category, and antiretroviral therapy on the progression of human immunodeficiency virus infection using multistate Markov models. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    Alioum A; Leroy V; Commenges D; Dabis F; Salamon R
    Epidemiology; 1998 Nov; 9(6):605-12. PubMed ID: 9799168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].
    Pezzotti P; Dorrucci M; Donisi A; Cusini M; Mazzarello G; De Luca A; Salassa B; Ursitti MA; Giuliani M; Rezza G;
    Epidemiol Prev; 2003; 27(6):348-55. PubMed ID: 15058363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term, medically supervised, drug-free treatment and methadone maintenance treatment on drug users' emergency department use and hospitalization.
    Turner BJ; Laine C; Yang CP; Hauck WW
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S457-63. PubMed ID: 14648464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence.
    Turner BJ; Laine C; Lin YT; Lynch K
    Arch Intern Med; 2005 Aug 8-22; 165(15):1769-76. PubMed ID: 16087826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.
    García de la Hera M; Ferreros I; del Amo J; García de Olalla P; Pérez Hoyos S; Muga R; del Romero J; Guerrero R; Hernández-Aguado I;
    J Epidemiol Community Health; 2004 Nov; 58(11):944-50. PubMed ID: 15483312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
    Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
    Wong KH; Chan KC; Lee SS
    Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.
    Wang C; Vlahov D; Galai N; Bareta J; Strathdee SA; Nelson KE; Sterling TR
    J Infect Dis; 2004 Sep; 190(6):1046-54. PubMed ID: 15319852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of human immunodeficiency virus infection among adults in Mumbai.
    Hira SK; Shroff HJ; Lanjewar DN; Dholkia YN; Bhatia VP; Dupont HL
    Natl Med J India; 2003; 16(3):126-31. PubMed ID: 12929853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
    Casoli C; Pilotti E; Bertazzoni U
    AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between AIDS disease progression rates and the Fok-I polymorphism of the VDR gene in a cohort of HIV-1 seropositive patients.
    Nieto G; Barber Y; Rubio MC; Rubio M; Fibla J
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):199-207. PubMed ID: 15225772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early participation in an HIV cohort study slows disease progression and improves survival. The Swiss HIV Cohort Study.
    Battegay M; Wirz M; Steuerwald MH; Egger M
    J Intern Med; 1998 Dec; 244(6):479-87. PubMed ID: 9893101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection.
    Kiwanuka N; Laeyendecker O; Robb M; Kigozi G; Arroyo M; McCutchan F; Eller LA; Eller M; Makumbi F; Birx D; Wabwire-Mangen F; Serwadda D; Sewankambo NK; Quinn TC; Wawer M; Gray R
    J Infect Dis; 2008 Mar; 197(5):707-13. PubMed ID: 18266607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus load.
    Lyles CM; Dorrucci M; Vlahov D; Pezzotti P; Angarano G; Sinicco A; Alberici F; Alcorn TM; Vella S; Rezza G
    J Infect Dis; 1999 Oct; 180(4):1018-24. PubMed ID: 10479126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein is a marker for human immunodeficiency virus disease progression.
    Lau B; Sharrett AR; Kingsley LA; Post W; Palella FJ; Visscher B; Gange SJ
    Arch Intern Med; 2006 Jan; 166(1):64-70. PubMed ID: 16401812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of highly active antiretroviral therapy on multiple AIDS-defining illnesses among male HIV seroconverters.
    Cain LE; Cole SR; Chmiel JS; Margolick JB; Rinaldo CR; Detels R
    Am J Epidemiol; 2006 Feb; 163(4):310-5. PubMed ID: 16371516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of progression to AIDS or death after HIV diagnosis, United States, 1996 to 2001.
    Hall HI; McDavid K; Ling Q; Sloggett A
    Ann Epidemiol; 2006 Nov; 16(11):824-33. PubMed ID: 17067817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.